EDGAR Filing Documents for 0001104659-16-109722

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001104659-16-109722

Filing Date

2016-04-05

Accepted

2016-04-05 06:48:24

Documents

Period of Report

2015-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	20-F	a16-7190_120f.htm	20-F	8812152
2	EX-12.1	a16-7190_1ex12d1.htm	EX-12.1	13201
3	EX-12.2	a16-7190_1ex12d2.htm	EX-12.2	12556
4	EX-13.1	a16-7190_1ex13d1.htm	EX-13.1	9427
5	GRAPHIC	g71901bc11i001.jpg	GRAPHIC	12654
6	GRAPHIC	g71901csi001.gif	GRAPHIC	61506
7	GRAPHIC	g71901csi002.gif	GRAPHIC	61731
8	GRAPHIC	g71901csi003.gif	GRAPHIC	56950
9	GRAPHIC	g71901csi004.gif	GRAPHIC	56556
10	GRAPHIC	g71901csi005.gif	GRAPHIC	55579
11	GRAPHIC	g71901csi006.gif	GRAPHIC	57836
	Complete submission text file	0001104659-16-109722.txt		9348871

Mailing Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036

Business Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036 212-969-3335

IRS No.: 000000000
Type: 20-F | Act: 34 | File No.: 001-35193 | Film No.: 161552973
SIC: 2834 Pharmaceutical Preparations